- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: Brain Anatomy.
Displaying page 1 of 1.
EudraCT Number: 2014-001012-19 | Sponsor Protocol Number: CFTY720DNL02T | Start Date*: 2014-12-17 |
Sponsor Name:VU University Medical Center | ||
Full Title: Effects of fingolimod on functional brain adaptation and clinical measures in multiple sclerosis | ||
Medical condition: Relapsing-remitting (RR) multiple sclerosis (MS) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023007-10 | Sponsor Protocol Number: TF2010 | Start Date*: 2011-03-22 | |||||||||||
Sponsor Name:Uppsala university | |||||||||||||
Full Title: A neuroscience perspective on anxiety proneness - Sex differences, monoaminergic pathways and treatment response | |||||||||||||
Medical condition: Men and women diagnosed with DSM-IV social phobia (social anxiety disorder) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005555-27 | Sponsor Protocol Number: ESR-14-10473 | Start Date*: 2017-09-12 |
Sponsor Name:University Hospital Basel | ||
Full Title: Prevention of Cerebral Ischaemia in Stent Treatment for Carotid Artery Stenosis - A randomised multi-centre phase II trial comparing Ticagrelor versus Clopidogrel with outcome assessment on MRI (PR... | ||
Medical condition: Carotid artery stenting (CAS) is treatment for atherosclerotic carotid stenosis. The main adverse events are thromboembolic brain infarcts during the procedure. Ticagrelor, a novel reversible inhib... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) NL (Completed) GB (GB - no longer in EU/EEA) BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001252-35 | Sponsor Protocol Number: DANA-2018-1. | Start Date*: 2018-09-06 |
Sponsor Name:Kirsten Møller | ||
Full Title: Neuroplasticity induced by general anaesthesia | ||
Medical condition: This trial investigates the effects of general anaesthesia on the helathy human brain. Thus, only healthy, young adults with no medical conditions will participate as volunteers in this study. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001288-58 | Sponsor Protocol Number: 40122 | Start Date*: 2012-05-21 | |||||||||||
Sponsor Name:Academic Medical Center | |||||||||||||
Full Title: Boosting oxytocin after trauma: The effects of intranasal oxytocin administration on emotional and motivational brain processes in PTSD | |||||||||||||
Medical condition: Posttraumatic Stress Disorder (PTSD) according to criteria in the DSM-IV | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005518-16 | Sponsor Protocol Number: U3P | Start Date*: 2021-05-10 | |||||||||||
Sponsor Name:Universitätsklinikum Erlangen | |||||||||||||
Full Title: U3P study - Upadacitinib in Psoriatic Arthritis Pain Processing | |||||||||||||
Medical condition: Psoriatic arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004175-73 | Sponsor Protocol Number: HP-CD-CL-2002 | Start Date*: 2017-09-27 | |||||||||||
Sponsor Name:Herantis Pharma Plc | |||||||||||||
Full Title: A Phase I-II, Randomised, Double-Blind, Placebo Controlled, Safety and Tolerability Study of Intermittent Bilateral Intraputamenal Cerebral Dopamine Neurotrophic Factor (CDNF) Infusions Administere... | |||||||||||||
Medical condition: Idiopathic Parkinson's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001055-40 | Sponsor Protocol Number: 111-209 | Start Date*: 2020-07-29 | |||||||||||
Sponsor Name:BioMarin Pharmaceutical Inc. | |||||||||||||
Full Title: A randomized, controlled, open-label clinical trial with an open-label extension to investigate the safety of BMN 111 in infants and young children with achondroplasia at risk of requiring cervicom... | |||||||||||||
Medical condition: achondroplasia | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003050-41 | Sponsor Protocol Number: HJE-PHARMA-001 | Start Date*: 2015-11-10 | |||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||
Full Title: Efficacy of GLP-1 agonists and restrictive vs. liberal FiO2 in patients undergoing coronary artery bypass grafting or aortic valve replacement – a 2-by-2 factorial designed, randomized clinical study | |||||||||||||
Medical condition: We investigate the efficacy of commercially available GLP-1 analog for reducing organ damage in patients undergoing heart surgery (i.e. coronary artery bypass grafting and/or aortic valve replaceme... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004868-30 | Sponsor Protocol Number: PNET5MB | Start Date*: 2013-10-31 | |||||||||||
Sponsor Name:University Medical Center Hamburg-Eppendorf | |||||||||||||
Full Title: AN INTERNATIONAL PROSPECTIVE TRIAL ON MEDULLOBLASTOMA (MB) IN CHILDREN OLDER THAN 3 TO 5 YEARS WITH WNT BIOLOGICAL PROFILE (PNET 5 MB – LR and PNET 5 MB – WNT-HR), AVERAGE-RISK BIOLOGICAL PROFILE (... | |||||||||||||
Medical condition: Children with medulloblastoma. Medulloblastoma is a highly cellular malignant embryonal neoplasm. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Restarted) BE (Ongoing) IT (Ongoing) FR (Ongoing) FI (Ongoing) SE (Ongoing) ES (Ongoing) GB (GB - no longer in EU/EEA) AT (Ongoing) NO (Completed) CZ (Ongoing) NL (Ongoing) DK (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.